Matrix Metalloproteinases: A Therapeutic Target in Cardiovascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|13|1033-1040

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.13, 2003-05, pp. : 1033-1040

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Therapeutic Approaches Targeting Matrix Metalloproteinases in Cardiovascular Disease

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-05 ,pp. : 1214-1221

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease

By  

Current Pharmaceutical Design, Vol. 13, Iss. 17, 2007-06 ,pp. : 1787-1802

Bentham Science Publishers

Access to resources Recommend Favorite

The endothelin system:a novel therapeutic target in cardiovascular disease

By Strachan F.E.   Webb D.J.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 95-112

Informa Healthcare

Access to resources Recommend Favorite

NF-κB as a Therapeutic Target for Cardiovascular Disease

By  

Heart Drug, Vol. 2, Iss. 6, 2003-04 ,pp. : 303-311

Karger

Access to resources Recommend Favorite

Matrix Metalloproteinases in Coronary Artery Disease:Clinical and Therapeutic Implications and Pathological Significance

By  

Current Medicinal Chemistry, Vol. 12, Iss. 8, 2005-04 ,pp. : 917-925

Bentham Science Publishers

Access to resources Recommend Favorite